Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon (Q27487518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Adrian M. Di Bisceglie

object named as

Adrian M Di Bisceglie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Herbert L Bonkovsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Timothy R Morgan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mitchell L Shiffman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gregory T Everson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Karen L Lindsay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

James E Everhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Elizabeth C Wright

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

William M Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Anna S Lok

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marc G Ghany

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chihiro Morishima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kristin K Snow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

HALT-C Trial Investigators

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2429-2441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

17 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Histological grading and staging of chronic hepatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Peginterferon and ribavirin for chronic hepatitis C.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Global burden of disease (GBD) for hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Chronic hepatitis: morphology and nomenclature.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Transection of the oesophagus for bleeding oesophageal varices

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Statistics in medicine--reporting of subgroup analyses in clinical trials.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2606037

Natural history of hepatitis C

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19052125

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA0707615

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

19052125

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052125%20AND%20SRC:MED&resulttype=core&format=json